Literature DB >> 7228877

Kinetic analysis of the nonenzymatic glycosylation of hemoglobin.

P J Higgins, H F Bunn.   

Abstract

The rate constants have been derived for (a) the condensation of glucose with hemoglobin to form the labile Schiff base intermediate, pre-AIc; (b) the dissociation of this complex to hemoglobin and glucose; (c) the rearrangement of this complex to form the stable ketoamine, Hb AIc. These measurements required the purification of commercially available D-[14C]glucose in order to remove a rapidly reacting contaminant. The initial condensation reaction rate (kappa'1) was measured by incubating column purified Hb A0 for up to 8 h under physiologic conditions with purified D-[14C]glucose in the presence of cyanoborohydride which traps the Schiff base and reduces it to a stable adduct. A parallel incubation utilizing Hb AIc revealed the contribution of the beta-NH2-terminal amino group (kappa 1) to the overall value for kappa'1. The reverse reaction rate (kappa -1) was determined from incubations carried ut in the absence of cyanoborohydride. The rate of the Amadori rearrangement (kappa 2) was determined from longer (6-21 days) incubations under identical conditions, followed by chromatographic isolation of Hb AIc. This value for kappa 2 agrees well with one we previously obtained from in vivo data. These experiments provide direct chemical evidence for an aldimine precursor in the nonenzymatic glycosylation of protein. Furthermore, the use of these rate constants provides a reasonable estimate of the distribution of the labile aldimine (pre-AIc) and the stable ketoamine (Hb AIc) in normal and diabetic red cells. This information is useful in the interpretation of measurements of glycosylated hemoglobin in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

2.  Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.

Authors:  Eric P Smith; Robert M Cohen
Journal:  J Diabetes Sci Technol       Date:  2015-02-17

3.  Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring.

Authors:  Roy Malka; David M Nathan; John M Higgins
Journal:  Sci Transl Med       Date:  2016-10-05       Impact factor: 17.956

4.  Labile haemoglobin as a glycaemic biomarker for patient-specific monitoring of diabetes: mathematical modelling approach.

Authors:  O León-Triana; G F Calvo; J Belmonte-Beitia; M Rosa Durán; J Escribano-Serrano; A Michan-Doña; V M Pérez-García
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

5.  Protein modification by acrolein: formation and stability of cysteine adducts.

Authors:  Jian Cai; Aruni Bhatnagar; William M Pierce
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

6.  Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Authors:  H P Hammes; S S Ali; M Uhlmann; A Weiss; K Federlin; K Geisen; M Brownlee
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

Authors:  Y Fong; D Edelstein; E A Wang; M Brownlee
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

8.  An Innovative Mathematical Model: A Key to the Riddle of HbA(1c).

Authors:  Mahdi Kahrom
Journal:  Int J Endocrinol       Date:  2010-08-29       Impact factor: 3.257

9.  In-depth comparative characterization of hemoglobin glycation in normal and diabetic bloods by LC-MSMS.

Authors:  Shih-Hao Wang; Tzu-Fan Wang; Chih-Hsing Wu; Shu-Hui Chen
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-28       Impact factor: 3.109

10.  Separation of glycosylated haemoglobins using immobilized phenylboronic acid. Effect of ligand concentration, column operating conditions, and comparison with ion-exchange and isoelectric-focusing.

Authors:  F A Middle; A Bannister; A J Bellingham; P D Dean
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.